Christina M Sheerin1, Mackenzie J Lind1, Emily A Brown1,2, Charles O Gardner1, Kenneth S Kendler1,3, Ananda B Amstadter1,3. 1. Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University School of Medicine, Richmond, VA, USA. 2. Department of Public Health, Drexel University, Philadelphia, PA, USA. 3. Department of Human and Molecular Genetics, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
Abstract
BACKGROUND: There remains a dearth of research examining the "buffering" effect of resilience, wherein resilience at one point in time would be expected to protect an individual against development of psychopathology following future adverse life events. METHODS: Using longitudinal data from an epidemiological twin sample (N = 7463), this study tested whether resilience would act as a buffer for stressful life events (SLEs) against risk for major depressive disorder (MDD) and generalized anxiety disorder (GAD). Resilience, demographics, and psychopathology were measured at Time 1 and recent SLEs and current MDD and GAD were measured at Time 2. RESULTS: Final models, controlling for demographic covariates and Time 1 diagnosis, examined the impact of Time 1 resilience, recent SLEs, their interaction, and a three-way interaction adding sex on MDD and GAD. CONCLUSIONS: The pattern of findings was the same for MDD and GAD, wherein main effects and two-way interactions of resilience and SLEs were significant, such that greater resilience was protective even in the context of high numbers of past-year SLEs. The three-way interaction was not significant, suggesting that the relationship between SLEs and resilience on psychopathology was the same for both men and women. Findings support the conceptualization of resilience as a buffer against the impact of future life stressors on common internalizing psychopathology. Longitudinal designs and trajectory-based studies that include recurring measures of SLEs could inform conceptualizations of resilience in the context of ongoing adversity and aid in developing interventions aimed at fostering healthy adaptation in the face of stressors.
BACKGROUND: There remains a dearth of research examining the "buffering" effect of resilience, wherein resilience at one point in time would be expected to protect an individual against development of psychopathology following future adverse life events. METHODS: Using longitudinal data from an epidemiological twin sample (N = 7463), this study tested whether resilience would act as a buffer for stressful life events (SLEs) against risk for major depressive disorder (MDD) and generalized anxiety disorder (GAD). Resilience, demographics, and psychopathology were measured at Time 1 and recent SLEs and current MDD and GAD were measured at Time 2. RESULTS: Final models, controlling for demographic covariates and Time 1 diagnosis, examined the impact of Time 1 resilience, recent SLEs, their interaction, and a three-way interaction adding sex on MDD and GAD. CONCLUSIONS: The pattern of findings was the same for MDD and GAD, wherein main effects and two-way interactions of resilience and SLEs were significant, such that greater resilience was protective even in the context of high numbers of past-year SLEs. The three-way interaction was not significant, suggesting that the relationship between SLEs and resilience on psychopathology was the same for both men and women. Findings support the conceptualization of resilience as a buffer against the impact of future life stressors on common internalizing psychopathology. Longitudinal designs and trajectory-based studies that include recurring measures of SLEs could inform conceptualizations of resilience in the context of ongoing adversity and aid in developing interventions aimed at fostering healthy adaptation in the face of stressors.
Authors: Howard Liu; Maria V Petukhova; Nancy A Sampson; Sergio Aguilar-Gaxiola; Jordi Alonso; Laura Helena Andrade; Evelyn J Bromet; Giovanni de Girolamo; Josep Maria Haro; Hristo Hinkov; Norito Kawakami; Karestan C Koenen; Viviane Kovess-Masfety; Sing Lee; Maria Elena Medina-Mora; Fernando Navarro-Mateu; Siobhan O'Neill; Marina Piazza; José Posada-Villa; Kate M Scott; Victoria Shahly; Dan J Stein; Margreet Ten Have; Yolanda Torres; Oye Gureje; Alan M Zaslavsky; Ronald C Kessler Journal: JAMA Psychiatry Date: 2017-03-01 Impact factor: 21.596
Authors: Sandro Galea; Chris R Brewin; Michael Gruber; Russell T Jones; Daniel W King; Lynda A King; Richard J McNally; Robert J Ursano; Maria Petukhova; Ronald C Kessler Journal: Arch Gen Psychiatry Date: 2007-12
Authors: Rozita Jalilianhasanpour; Benjamin Williams; Isabelle Gilman; Matthew J Burke; Sean Glass; Gregory L Fricchione; Matcheri S Keshavan; W Curt LaFrance; David L Perez Journal: J Psychosom Res Date: 2018-02-13 Impact factor: 3.006
Authors: Christina M Sheerin; Daniel Bustamante; Kaitlin E Bountress; Shannon E Cusack; Steven H Aggen; Kenneth S Kendler; Ananda B Amstadter Journal: Behav Genet Date: 2021-04-24 Impact factor: 2.805
Authors: Christina M Sheerin; Kaitlin E Bountress; Terrell A Hicks; Mackenzie J Lind; Steven H Aggen; Kenneth S Kendler; Ananda B Amstadter Journal: Subst Use Misuse Date: 2021-05-25 Impact factor: 2.362
Authors: Alexis K Johnson; Sharonne N Hayes; Craig Sawchuk; Matthew P Johnson; Patricia J Best; Rajiv Gulati; Marysia S Tweet Journal: J Am Heart Assoc Date: 2020-04-28 Impact factor: 5.501